Updated November 9, 2015 This content is archived.
Judges at the 43North business plan competition were impressed with the science behind Cytocybernetics, one of the winners of $500,000 in the competition for startups. The company — created by Glenna C. Bett, PhD, associate professor of obstetrics and gynecology, and Randall L. Rasmusson, PhD, professor of physiology and biophysics — is developing biotechnology that could halve the time and money needed to bring new drugs to the market.